UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Oligonucleotide Drugs for Transthyretin Amyloidosis

The New England journal of medicine, 2018-07, Vol.379 (1), p.82-85

Buxbaum, Joel N

2018

Volltextzugriff (PDF)

Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines

Amyloid, 2016-10, Vol.23 (4), p.209-213

2016

Volltextzugriff (PDF)

The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander

Journal of integrative neuroscience, 2023-11, Vol.22 (6), p.158-158

Buxbaum, Joel N

2023

Volltextzugriff (PDF)

Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis

Amyloid, 2014-12, Vol.21 (4), p.221-224

2014

Volltextzugriff (PDF)

Stress-responsive regulation of extracellular proteostasis

The Journal of cell biology, 2022-04, Vol.221 (4), p.1

2022

Volltextzugriff (PDF)

Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Molecular neurodegeneration, 2011-11, Vol.6 (1), p.79-79

2011

Volltextzugriff (PDF)

Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity

Biochemistry (Easton), 2013-03, Vol.52 (11), p.1913-1926

2013

Volltextzugriff (PDF)

The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans

The New England journal of medicine, 2015-01, Vol.372 (1), p.21-29

2015

Volltextzugriff (PDF)

Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans

Amyloid, 2015-07, Vol.22 (3), p.171-174

2015

Volltextzugriff (PDF)

Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (7), p.2681-2686

2008

Volltextzugriff (PDF)

The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice

The Journal of neuroscience, 2014-05, Vol.34 (21), p.7253-7265

2014

Volltextzugriff (PDF)

Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs

Biochemical and biophysical research communications, 2011-07, Vol.410 (4), p.707-713

2011

Volltextzugriff (PDF)

Tissue Damage in the Amyloidoses: Transthyretin Monomers and Nonnative Oligomers Are the Major Cytotoxic Species in Tissue Culture

Proceedings of the National Academy of Sciences - PNAS, 2004-03, Vol.101 (9), p.2817-2822

2004

Volltextzugriff (PDF)

Identification of transthyretin as a novel interacting partner for the δ subunit of GABAA receptors

PloS one, 2019, Vol.14 (1), p.e0210094-e0210094

2019

Volltextzugriff (PDF)

Transthyretin Deposition in Articular Cartilage: A Novel Mechanism in the Pathogenesis of Osteoarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (8), p.2097-2107

2015

Volltextzugriff (PDF)

Animal models of human amyloidoses: Are transgenic mice worth the time and trouble?

FEBS letters, 2009-08, Vol.583 (16), p.2663-2673

Buxbaum, Joel N.

2009

Volltextzugriff (PDF)

Transthyretin deposition promotes progression of osteoarthritis

Aging cell, 2017-12, Vol.16 (6), p.1313-1322

2017

Volltextzugriff (PDF)

Oligonucleotide Drugs for Transthyretin Amyloidosis

The New England journal of medicine, 2018-07, Vol.379 (1), p.82-85

Buxbaum, Joel N

2018

Volltextzugriff (PDF)

An Adaptable Standard for Protein Export from the Endoplasmic Reticulum

Cell, 2007-11, Vol.131 (4), p.809-821

2007

Volltextzugriff (PDF)

Transthyretin V122I (pV142I) cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans

Genetics in medicine, 2017-07, Vol.19 (7), p.733-742

2017

Volltextzugriff (PDF)

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis

Hemato, 2021-12, Vol.2 (4), p.645-659

2021

Volltextzugriff (PDF)

Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis

Amyloid, 2019-01, Vol.26 (1), p.10-14

2019

Volltextzugriff (PDF)

Unravelling Alzheimer's Disease: It's Not the Whole Story, but Aβ Still Matters

The FASEB journal, 2019-09, Vol.33 (9), p.9701-9705

Buxbaum, Joel N.

2019

Volltextzugriff (PDF)

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2020-10, Vol.27 (4), p.217-222

2020

Volltextzugriff (PDF)

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2018-10, Vol.25 (4), p.215-219

2018

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(139)
Buchkapitel
(2)

Sprache

Englisch
(141)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oligonucleotide Drugs for Transthyretin Amyloidosis

Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines

The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander

Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis

Stress-responsive regulation of extracellular proteostasis

Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity

The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans

Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans

Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity

The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice

Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs

Tissue Damage in the Amyloidoses: Transthyretin Monomers and Nonnative Oligomers Are the Major Cytotoxic Species in Tissue Culture

Identification of transthyretin as a novel interacting partner for the δ subunit of GABAA receptors

Transthyretin Deposition in Articular Cartilage: A Novel Mechanism in the Pathogenesis of Osteoarthritis

Animal models of human amyloidoses: Are transgenic mice worth the time and trouble?

Transthyretin deposition promotes progression of osteoarthritis

Oligonucleotide Drugs for Transthyretin Amyloidosis

An Adaptable Standard for Protein Export from the Endoplasmic Reticulum

Transthyretin V122I (pV142I) cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis

Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis

Unravelling Alzheimer's Disease: It's Not the Whole Story, but Aβ Still Matters

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Suchergebnisse filtern